Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02483377 · ClinicalTrials.gov registry record
Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer
A clinical trial, sponsored by University of Southern California.
- Terminated
- Registry status
- 13
- Enrollment target
NCT02483377: Clinical Trial study, sponsored by University of Southern California.
NCT02483377 is a clinical trial that was terminated before completion, run by University of Southern California. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02483377 was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This research trial studies how well patient navigation and tailored treatment planning work in Latina patients with breast cancer. Patient navigation and tailored treatment planning may provide extra support by guiding patients through the healthcare system, remove barriers to care and provide ease of access to essential resources, encourage patient participation in their care, provide in-language summaries and plans for follow-up care, improve patient access to needed supportive care services and may improve general healthcare experience in Latina patients with breast cancer.
Primary Outcome
Questionnaire scores will be expressed as median values with 95% confidence intervals.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-03-05 |
| Est. Completion | 2017-02-07 |
Why NCT02483377 stopped before completion
NCT02483377 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT02483377 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02483377 about?
NCT02483377 is a clinical study titled "Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer". This research trial studies how well patient navigation and tailored treatment planning work in Latina patients with breast cancer. Patient navigation and tailored treatment planning may provide extra support by guiding patients through the healthcare system, remove barriers to care and provide ease...
What is the current status of trial NCT02483377?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2015-03-05. Estimated completion is 2017-02-07.
What interventions are being tested in trial NCT02483377?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT02483377?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI